Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Clindamycin Phosphate Patent Expiration

Clindamycin Phosphate was first introduced by Pfizer Inc in its drug Cleocin Phosphate on Approved Prior to Jan 1, 1982. Other drugs containing Clindamycin Phosphate are Cleocin T, Cleocin, Evoclin, Clindagel, Clindamycin Phosphate In 0.9% Sodium Chloride, Clindesse, Clindamycin Phosphate In Dextrose 5%, Clindamycin Phosphate In Dextrose 5% In Plastic Container, Xaciato, Cleocin Phosphate In Dextrose 5% In Plastic Container. 46 different companies have introduced drugs containing Clindamycin Phosphate.


Clindamycin Phosphate Patents

Given below is the list of patents protecting Clindamycin Phosphate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Xaciato US11129896 Topical formulations and treatments Sep 22, 2036 Organon Llc
Clindesse US9789057 Pharmaceutical delivery system Dec 02, 2026 Padagis Us
Evoclin US7141237 Pharmaceutical foam Feb 03, 2024

(Expired)

 Norvium Bioscience
Evoclin US7374747 Pharmaceutical foam Jan 23, 2024

(Expired)

 Norvium Bioscience
Clindesse US6899890 Bioadhesive drug delivery system Apr 27, 2023

(Expired)

 Padagis Us
Clindagel US6387383 Topical low-viscosity gel composition Aug 03, 2020

(Expired)

 Bausch
Cleocin US6495157 Intravaginal clindamycin ovule composition Jul 20, 2020

(Expired)

 Pfizer
Clindesse US5993856 Pharmaceutical preparations and methods for their administration Nov 17, 2017

(Expired)

 Padagis Us



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Clindamycin Phosphate's patents.

Given below is the list recent legal activities going on the following patents of Clindamycin Phosphate.

Activity Date Patent Number
Patent litigations
Change in Power of Attorney (May Include Associate POA)
Critical
 29 Dec, 2021 US11129896
Email Notification
Critical
 29 Dec, 2021 US11129896
Correspondence Address Change
Critical
 27 Dec, 2021 US11129896
Patent Issue Date Used in PTA Calculation
Critical
 28 Sep, 2021 US11129896
Recordation of Patent Grant Mailed
Critical
 28 Sep, 2021 US11129896
Email Notification
Critical
 09 Sep, 2021 US11129896
Issue Notification Mailed
Critical
 08 Sep, 2021 US11129896
Application Is Considered Ready for Issue
Critical
 25 Aug, 2021 US11129896
Dispatch to FDC 25 Aug, 2021 US11129896
Issue Fee Payment Verified
Critical
 23 Aug, 2021 US11129896


Clindamycin Phosphate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Clindamycin Phosphate Generic API Manufacturers

Several generic applications have been filed for Clindamycin Phosphate. The first generic version for Clindamycin Phosphate was by Pharmacia And Upjohn Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Apr 2, 2024.

Given below is the list of companies who have filed for Clindamycin Phosphate generic, along with the locations of their manufacturing plants worldwide.


1. ABBOTT LABS

Abbott Laboratories has filed for 3 different strengths of generic version for Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Abbott Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 12MG BASE/ML

injectable Discontinued INJECTION N/A Jun 29, 2001
EQ 6MG BASE/ML

injectable Discontinued INJECTION N/A Jun 29, 2001
EQ 18MG BASE/ML

injectable Discontinued INJECTION N/A Jun 29, 2001





2. ABRAXIS PHARM

Abraxis Pharmaceutical Products has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Jun 3, 1988





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

gel Prescription TOPICAL AB1 Apr 2, 2024


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Vadodara Alembic Pharmaceuticals, Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)





4. ALMAJECT

Almaject Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Almaject.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Prescription INJECTION AP Sep 29, 1988





5. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

gel Discontinued TOPICAL N/A Nov 3, 2022


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Piscataway Amneal Pharmaceuticals, LLC
Branchburg Amneal Pharmaceuticals, LLC
Paterson Amneal Pharmaceuticals, Llc
East Hanover Amneal Pharmaceuticals LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Glasgow Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
India
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Hyderabad Amneal Oncology Private Limited





6. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 3 different strengths of generic version for Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/ML

injectable Prescription INJECTION AP Jun 28, 2017
EQ 12MG BASE/ML

injectable Prescription INJECTION AP Jun 28, 2017
EQ 18MG BASE/ML

injectable Prescription INJECTION AP Jun 28, 2017





7. BEDFORD

Bedford Laboratories Div Ben Venue Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Bedford.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Jun 30, 1994


Manufacturing Plant Locations
New

Bedford's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bedford as present at those locations.

Country City Firm Name
United States
Shelbyville Bedford Cheese Store Inc
Curryville Bedford Farm Bureau Cooperative
Bedford Bedford Research Foundation, Inc.





8. BOCA PHARMA LLC

Boca Pharmacal Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Boca Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A Jan 11, 1989





9. BRISTOL MYERS SQUIBB

Bristol Myers Squibb Pharma Co has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Bristol Myers Squibb.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Feb 1, 1989


Manufacturing Plant Locations
New

Bristol Myers Squibb's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bristol Myers Squibb as present at those locations.

Country City Firm Name
United States
Mayaguez Bristol Myers Squibb Caribbean Company
Plainsboro Bristol Myers Squibb Company
Princeton Bristol Myers Squibb
Catano Bristol Myers Squibb Pr





10. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Prescription TOPICAL AT Feb 8, 2018





11. ENCUBE

Encube Ethicals Private Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

lotion Prescription TOPICAL AB Jan 18, 2022


Manufacturing Plant Locations
New

Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.

Country City Firm Name
India
Ponda Encube Ethicals Pvt. Ltd.
Andheri East, Mumbai Encube Ethicals Private Ltd





12. ENCUBE ETHICALS

Encube Ethicals Pvt Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Encube Ethicals.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Prescription TOPICAL AT Jan 28, 2019


Manufacturing Plant Locations
New

Encube Ethicals's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube Ethicals as present at those locations.

Country City Firm Name
India
Ponda Encube Ethicals Pvt. Ltd.
Andheri East, Mumbai Encube Ethicals Private Ltd





13. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A May 29, 2015





14. EPIC PHARMA LLC

Epic Pharma Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

swab Prescription TOPICAL AT Jun 17, 2010





15. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A Feb 14, 2006
EQ 2% BASE

cream Prescription VAGINAL AB Dec 27, 2004





16. FOUGERA PHARMS INC

Fougera Pharmaceuticals Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Prescription TOPICAL AT Jun 5, 1997





17. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Prescription INJECTION AP May 9, 2007


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Melrose Park Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
Grand Island Fresenius Kabi USA, LLC
North Andover Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Melrose Park Fresenius Kabi USA LLC
Lake Zurich Fresenius Kabi USA, LLC





18. G AND W LABS INC

G And W Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by G And W Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A Sep 1, 1988





19. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

gel Prescription TOPICAL AB1 Feb 10, 2021
1%

aerosol, foam Prescription TOPICAL AT Sep 20, 2021





20. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Clindamycin Phosphate. Out of these eq 18mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, eq 12mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, eq 6mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Prescription INJECTION AP Sep 24, 2004
EQ 18MG BASE/ML

injectable Prescription INJECTION AP Apr 5, 2023
EQ 12MG BASE/ML

injectable Prescription INJECTION AP Apr 5, 2023
EQ 6MG BASE/ML

injectable Prescription INJECTION AP Apr 5, 2023


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





21. IGI LABS INC

Igi Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Igi Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Feb 13, 1989





22. LOCH

Loch Pharmaceuticals Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Loch.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A May 9, 1988


Manufacturing Plant Locations
New

Loch's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Loch as present at those locations.

Country City Firm Name
United States
Union Lochirco Fruit & Produce Inc
Buffalo Lochness Medical, Inc.
Lodi Lochner Dairy, LLC
Fenton Lochhead Manufacturing Company
Junction City Lochmead Dairy Inc
Marthasville Lochirco Fruit and Produce, Inc.





23. MARSAM PHARMS LLC

Marsam Pharmaceuticals Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Marsam Pharms Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Oct 20, 1988





24. NOVAST LABS

Novast Laboratories Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A Sep 27, 1996





25. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

(reference standard)

aerosol, foam Prescription TOPICAL AT Mar 31, 2010
EQ 1% BASE

lotion Prescription TOPICAL AB Mar 8, 2021


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.





26. PADAGIS US

Padagis Us Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

(reference standard)

swab Prescription TOPICAL AT May 25, 2000


Manufacturing Plant Locations
New

Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.

Country City Firm Name
United States
Minneapolis Padagis US LLC





27. PAI HOLDINGS PHARM

Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A Dec 30, 2016





28. PFIZER

Pfizer Inc has filed for 1 generic for Clindamycin Phosphate. This eq 150mg base/ml version comes by the name CLEOCIN PHOSPHATE. Given below are the details of the strengths of this generic introduced by Pfizer.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Prescription INJECTION AP Oct 16, 1987


Manufacturing Plant Locations
New

Pfizer's manufacturing plants are situated in 8 countries - Singapore, United States, Canada, Belgium, Italy, Japan, Sweden, India. Given below are the details of these plant locations as well as the firm names of Pfizer as present at those locations.

Country City Firm Name
Singapore
Singapore Pfizer Asia Manufacturing Pte Ltd.
United States
New Haven Pfizer Clinical Research Unit
Cary Pfizer Inc
Parsippany Pfizer Inc.
Boulder Pfizer Boulder
New York Pfizer Inc.
Peapack Pfizer Inc
Brooklyn Pfizer, Inc.
San Diego Pfizer Inc.
Groton Pfizer, Inc.
Terre Haute Pfizer Inc
Chesterfield Pfizer Inc
Canada
Brandon Pfizer Canada ULC
Belgium
Anderlecht Pfizer Clinical Research Unit, Hopital Erasme
Italy
Aprilia Pfizer Consumer Manufacturing Italy S.r.l
Japan
Chita-Gun Pfizer Global Supply Japan Inc.
Sweden
Strangnas Pfizer Health AB
India
Visakhapatnam Pfizer Healthcare India Private Limited





29. PHARMACIA AND UPJOHN

Pharmacia And Upjohn Co has filed for 2 different strengths of generic version for Clindamycin Phosphate. Out of these eq 150mg base/ml version comes by the name CLEOCIN PHOSPHATE, eq 1% base version comes by the name CLEOCIN T. Given below are the details of the strengths of this generic introduced by Pharmacia And Upjohn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
EQ 1% BASE

solution Discontinued TOPICAL N/A Feb 8, 1982





30. QUAGEN

Quagen Pharmaceuticals Llc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Quagen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

gel Prescription TOPICAL AB1 Jul 29, 2020


Manufacturing Plant Locations
New

Quagen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Quagen as present at those locations.

Country City Firm Name
United States
West Caldwell Quagen Pharmacuticals, LLC
West Caldwell Quagen Pharma, LLC





31. RISING

Rising Pharma Holding Inc has filed for 4 different strengths of generic version for Clindamycin Phosphate. Out of these eq 6mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, eq 12mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, eq 18mg base/ml version comes by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/ML

injectable Prescription INJECTION AP Apr 4, 2013
EQ 12MG BASE/ML

injectable Prescription INJECTION AP Apr 4, 2013
EQ 18MG BASE/ML

injectable Prescription INJECTION AP Apr 4, 2013
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Oct 10, 2017


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Saddle Brook Rising Pharmaceuticals, Inc.
East Brunswick Rising Pharma Holding, Inc.
Livingston Risingsun Iodine Products Corp.
Phoenix Rising Sun Farms Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





32. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Prescription INJECTION AP Sep 30, 2011





33. SANDOZ INC

Sandoz Inc has filed for 3 different strengths of generic version for Clindamycin Phosphate. All of these versions come by the name CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Sandoz Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/ML

(reference standard)

injectable Prescription INJECTION AP May 31, 2012
EQ 12MG BASE/ML

(reference standard)

injectable Prescription INJECTION AP May 31, 2012
EQ 18MG BASE/ML

(reference standard)

injectable Prescription INJECTION AP May 31, 2012


Manufacturing Plant Locations
New

Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.

Country City Firm Name
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated





34. SOLARIS PHARMA CORP

Solaris Pharma Corp has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Solaris Pharma Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

gel Prescription TOPICAL AB2 Aug 13, 2021


Manufacturing Plant Locations
New

Solaris Pharma Corp's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Solaris Pharma Corp as present at those locations.

Country City Firm Name
United States
Bridgewater Solaris Pharma Corp





35. SOLOPAK

Solopak Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Solopak.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Mar 17, 1988





36. TARO

Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

aerosol, foam Prescription TOPICAL AT Mar 11, 2020
EQ 1% BASE

lotion Prescription TOPICAL AB Jun 28, 2021


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Honolulu Taro Delight, LLC
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





37. TARO PHARM INDS

Taro Pharmaceutical Industries Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Prescription TOPICAL AT Mar 31, 2004





38. TEVA PARENTERAL

Teva Parenteral Medicines Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Teva Parenteral.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A May 29, 1992


Manufacturing Plant Locations
New

Teva Parenteral's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Teva Parenteral as present at those locations.

Country City Firm Name
United States
Irvine Teva Parenteral Medicines, Inc.





39. VINTAGE PHARMS

Vintage Pharmaceuticals has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Vintage Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A Jun 28, 1989





40. WATSON LABS

Watson Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/ML

injectable Discontinued INJECTION N/A Mar 5, 1990





41. XTTRIUM LABS INC

Xttrium Laboratories Inc has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Xttrium Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

solution Discontinued TOPICAL N/A Jul 15, 1997





42. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 1 generic for Clindamycin Phosphate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1% BASE

gel Prescription TOPICAL AB1 Sep 19, 2023


Manufacturing Plant Locations
New

Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.

Country City Firm Name
India
Matoda Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Ankleshwar Zydus Lifesciences Limited
Jarod Zydus Lifesciences Limited
Thane Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Dabhasa Zydus Lifesciences Limited